| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.11 | 0.3 |